Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan.
about
Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoeaCarotid body chemoreceptors, sympathetic neural activation, and cardiometabolic diseaseThe impact of sleep disorders on glucose metabolism: endocrine and molecular mechanismsThe efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxiaCarotid body, insulin, and metabolic diseases: unraveling the links.Association between Glucose Metabolism and Sleep-disordered Breathing during REM Sleep.Reduced c-Fos expression in medullary catecholaminergic neurons in rats 20 h after exposure to chronic intermittent hypoxia.Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposureIntermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitusNeural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia.Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.Plasma Exosomes and Improvements in Endothelial Function by Angiotensin 2 Type 1 Receptor or Cyclooxygenase 2 Blockade following Intermittent Hypoxia.Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.Glucose homoeostasis in rats exposed to acute intermittent hypoxia.Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea.
P2860
Q26783727-27236281-8EF4-4693-908C-EF4124808FA8Q28076487-E661E1EB-4E3E-44E9-8A38-9C649D7E5EB1Q28390983-0EFD4E39-36A5-4B42-8A05-5DEADFC378F4Q30428971-23AE3705-988A-4BB0-A906-C969B73E7BFEQ34295327-E5C519A2-FCD0-45C8-B5AC-41A65C20170EQ34419319-E630B282-83D3-4AAF-9201-5EAA4B73ABC3Q36272390-8FAD4473-6DF0-4B67-913C-695E0EC5A7C0Q36770711-DF9B0AF3-0068-4A04-A290-956F25192813Q37171152-2889345F-0DA7-4309-84AC-51B4F79E18E2Q37301887-EABBF5EB-E5CA-4FA1-B363-415764620868Q37591858-BFC9A2FA-DFCC-4EA0-8817-49B9CF724783Q42082788-F86A39D4-7294-45FB-9C99-619CBCE161B7Q42368273-03027178-91BB-48E5-9C49-9C5D86D0CF11Q47647689-64FC2B2E-4751-4A2A-9255-7B354C0CCEDBQ47799206-9957D213-F62B-4610-8FB1-EE171FEDE663Q50974352-1B806205-FB24-4F1B-8099-165BCE413BF1Q55346247-620FFD60-5E48-4B4C-9461-171F5A944A02
P2860
Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Glucoregulatory consequences a ...... tion of exposure and losartan.
@ast
Glucoregulatory consequences a ...... tion of exposure and losartan.
@en
type
label
Glucoregulatory consequences a ...... tion of exposure and losartan.
@ast
Glucoregulatory consequences a ...... tion of exposure and losartan.
@en
prefLabel
Glucoregulatory consequences a ...... tion of exposure and losartan.
@ast
Glucoregulatory consequences a ...... tion of exposure and losartan.
@en
P2093
P2860
P356
P1476
Glucoregulatory consequences a ...... tion of exposure and losartan.
@en
P2093
Jennifer L Branconi
Leszek Kubin
Richard O Davies
Tyana Singletary
Victor B Fenik
P2860
P356
10.3389/FNEUR.2012.00051
P50
P577
2012-04-09T00:00:00Z